Responses included conditions such as asthma, Hashimoto’s thyroiditis, glucose-6-phosphate dehydrogenase (G6PD) deficiency, sickle cell disease, psoriasis, polycystic ovary syndrome (PCOS), hypercholesterolemia, obesity, hepatitis B infection, migraines, bipolar disorder, gout, spondylarthritis, gastroesophageal reflux disease (GERD), and irritable bowel syndrome (IBS). This evidence concerns the gene G6PD and gastroesophageal reflux disease.